| |
New Events and other meetings
Pharmacovigilance courses
We have been notified of the following courses of interest to pharmacovigilantes:
Drug Safety Research Unit (UK) Education & Research Courses
For updates, please contact :
E-mail: Jan Phillips at the DSRU or for more information click http://www.dsru.org/shortcourses_training.html
- Compliance in Pharmacovigilance and the role of the EU qualified person, 21/22 May 2008
- Periodic Safety Update Reports (PSURs), 4/5 June 2008
ISPE Meetings
- Mid-Year Meeting 2008 April 26-29, 2008 Boston, Massachusetts
- 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 17-20, 2008 Copenhagen, Denmark
abstract submission
E-mail: ispe@paimgmt.com
http://www.pharmacoepi.org/
First National Congress of Pharmacovigilance in Turkey
Organised by the Turkish Pharmacovigilance Association
4-6 June 2008, Antakya Hatay, Turkey
More information, contact website: www.farmakovijilansdernegi.org
email: kongre@farmakovijilansdernegi.org
44th Annual DIA Meeting, Boston, USA, June 22-26, 2008
2008 DIA Annual Meeting web site
IXth World Conference on Clinical Pharmacology & Therapeutics (CPT 2008)
CPT2008 Québec
27th July - 1st August, 2008
Québec City Convention Centre, Québec, Canada.
ISoP Joint session with IUPHAR Clinical Division for CPT 2008 (Medicines and Society) will take place on 29th July 2008 at 15.15 (stream 3).
The Conference programme is now finalized: http://www.cpt2008.org/e_mainmenu/welcome_e.shtml
British Pharmacological Society
6th James Black Conference 'New Pain Concepts and Future Treatments'
August 16-17, 2008 University of St Andrews, Scotland UK
Flyer, programme, registration forms, etc. on BPS website
15th ICPM september 2008 : Developing pharmaceutical care: medicines after the blockbuster era
15th ICPM 2008, 7th-10th September 2008, Amsterdam, The Netherlands.
“Developing pharmaceutical care: medicines after the blockbuster era”.
More information can be found on www.icpm2008.org.
Uppsala Conference 2008:
Impacting patient safety: Adverse drug reaction signal detection
Alfvnsalen, Uppsala, Sweden
Friday 24th October 2008, 8.30 am - 5.30 pm
Details and a booking form from the UMC website: www.who-umc.org
Congreso de Farmacovigilancia
Organized by the Mexican Association of Pharmacovigilance
6th-7th November 2008
Hotel Sede: Hyatt Regency Acapulco, Mexico
http://www.farmacovigilancia.org.mx/
3-weeks international Courses in "Special Topics in Epidemiology and Biostatistics" - Rome, Italy
10 Nov-28 Nov 2008
Topics are: Clinical Epidemiology (A.Hofman), Meta-analysis (J.P.A. Ioannidis), Evidence-based genome research in medicine: from genetic epidemiology to public health application' (C.M. van DUijn and A.c.J.W. Janssens).
Fifty percent reduced fees are reserved for the first ten applicants provided specific requirements detailed on the first page left of the leaflet.
For each single Course only the first 40 admission requests will be considered. Registration closes on 1st Oct, 2008. Detailed information in the leaflet, or on the following website: http://www.rm.unicatt.it/igiene/epidemiology.
(Courses are independent from each other)
London School of Hygiene and Tropical Medicine
CERTIFICATE COURSE IN PHARMACOEPIDEMIOLOGY AND PHARMACOVIGILANCE
This examined course takes place in three 4 day teaching blocks, commencing on 10th Nov 2008 and is particularly relevant to those working in pharmacovigilance.
More details may be found on the school website www.lshtm.ac.uk/courses or by contacting the co-organiser Ann.Arscott@lshtm.ac.uk in the first instance.
Ligand-Gated Ion Channels. 18 th Neuropharmacology Conference in association with IUPHAR
November 12-14, 2008
Sheraton National Hotel, Washington DC, USA
www.neuropharmacology-conference.elsevier.com
Abstract submission deadline: June 13, 2008
Secretariat: Charlotte Wilkins
Neuropharmacology Conference
Elsevier, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK
Tel: +44 (0) 1865 843089 | Fax: +44 (0) 1865 843958
E-mail: ch.wilkins@elsevier.com
Annual Meeting ASCEPT in conjunction with the 4 th Australian Health and Medical Research Congress
November 16-21st 2008 at the Brisbane Exhibition and Convention Centre.
Information and specific program details are available at www.ahmrcongress.org.au
European Association for Clinical Pharmacology and Therapeutics (EACPT)
9th Congress of the EACPT
July 12-15, 2009 Edinburgh, Scotland.
http://www.eacpt2009.org/
Erice Manifesto
Last June, in Erice (Sicily) a group of twenty-seven experts in pharmacovigilance discussed and debated the global reform of the safety of medicines for patiets (The Erice Manifesto is published in Drug Safety journal).
Special Article : The Erice Manifesto
Drug Benefits and Risks: International Textbook of Clinical Pharmacology
Editors: Chris van Boxtel, Budiono Santoso, Ralph Edwards
ISBN: 0-471-89927-5, 734 pages, published November 2001
This book looks at practical therapeutics and the surrounding general and pharmaceutical knowledge: an inclusive reference to the scientific basis and practice of drug therapy.
The key concept is looking at the balance between the benefits and risks of drugs and the social impact which drugs have in modern societies. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. The book covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases gives guidance on how doctors should act so that drugs can be used effectively and safely encourages the rational use of drugs in society. This book will be invaluable for anyone working within, or associated with, the field of clinical pharmacology and pharmacotherapy - undergraduates, postgraduates, regulatory authorities and the pharmaceutical industry.
London declaration
|
PATIENT AND CONSUMER ORGANIZATIONS WELCOME OUTCOMES OF WORLD HEALTH ORGANIZATION FIRST PATIENTS FOR PATIENT SAFETY WORKSHOP
London, United Kingdom, 8 February 2006 - Today, patient and consumer organizations joined together to welcome the publication of the London Declaration from Patients for Patient Safety following the World Health Organization's (WHO) first Patients for Patient Safety workshop last year. The International Alliance of Patients' Organizations (IAPO) and Consumers Advancing Patient Safety (CAPS) commended the WHO on incorporating the patients' voice in a meaningful way into the WHO World Alliance for Patient Safety and congratulated Patients for Patient Safety on its achievements to date. Patients for Patient Safety is one of six action areas of the WHO World Alliance for Patient Safety.
"Patients must be at the centre of our quest to improve patient safety" said Sir Liam Donaldson, Chair of the World Alliance for Patient Safety. "When things go wrong, they and their families suffer from any harm caused. Patients for Patient Safety is designed to ensure that patients and their families are a central part of international efforts to improve patient safety through this WHO Alliance".
The groundbreaking Patients for Patient Safety workshop was held in London, 27-30 November 2005 running in parallel to the EU Summit on Patient Safety, organized by the UK Government in its role of Presidency of the EU during 2005. Following a competitive application process, 24 patient and consumer advocates - patient safety champions - were selected together representing 21 countries across developed, transitional and developing countries, providing a truly global voice.
The key outcome of the workshop was the publication of the London Declaration through which the patient safety champions expressed their vision for safer health care systems worldwide and highlighted concrete areas where patients and consumers - and the organizations that represent them - can work in partnership with health providers to make a significant contribution to the improvement of patient safety.
"We learned from the 24 thoughtful patient safety champions that challenges in delivering safe, compassionate health care cut across all geographic, ethnic and socio-economic boundaries", said Susan E. Sheridan, MIM, MBA, CAPS Co-Founder and President and Lead of Patients for Patient Safety. "The London Declaration will be the soul of the work of the World Alliance".
IAPO and CAPS congratulated the workshop participants for their incredible focus and skill in defining and developing the role of patients and consumers in the WHO's World Alliance for Patient Safety. In addition to the concrete outcomes, the workshop was also an important signal of highlighted the importance of the patient voice in health policy-making.
IAPO and CAPS have announced their support for the London Declaration with its commitment to harness the expertise, knowledge and motivation of consumers and patients to work through partnerships to improve patient safety for all patients. IAPO Chair, Albert van der Zeijden, commented, "This Declaration demonstrates the strong commitment of consumers and patients, and the organizations that represent them, to contribute their knowledge and expertise to improve patient safety in a structured and effective way".
-------
Note to Editors:
1. CAPS is a consumer-led non-profit organization formed to be a collective voice for individuals, families and healers who wish to prevent harm in healthcare encounters through partnership and collaboration. CAPS envisions a partnership between consumers and providers to create global healthcare systems that are safe, compassionate and just. Susan E. Sheridan, MIM, MBA, CAPS Co-founder and President, also leads Patients for Patient Safety, the consumer action area of the WHO World Alliance.
2. IAPO is the only global alliance representing patients of all nationalities across all disease areas and promoting patient-centred healthcare worldwide. Our members are patients' organizations working at the local, national, regional and international levels to represent and support patients, their families and carers. A patient is a person with any chronic disease, illness, syndrome, impairment or disability. IAPO was founded in 1999 by forty patients' organizations from around the world.
3. Patients for Patient Safety is one of the six action areas of the World Alliance for Patient Safety and is designed to ensure that the perspective of patients and families, consumers and citizens - whichever term resonates best - in both developed and developing countries is a central reference point in shaping the important work of the Alliance.
4. The patient champions selected were from 21 countries: Argentina; Australia; Canada; China; Egypt; Fiji; Germany; India; Italy; Mexico; The Netherlands; Nigeria; Pakistan; Poland; Sudan; Uganda; Ukraine; United Kingdom; United States of America; Yemen and Zambia.
5. The London Declaration is available online here.
6. For a full copy of this press release, please click here.
For further information, please contact:
Mr Mitchell Dvorak
Executive Director
Consumers Advancing Patient Safety (CAPS)
Tel: (312) 274-1301
Fax: (312) 274-9696
Email: mdvorak@patientsafety.org
Website: www.patientsafety.org
Ms Jo Harkness
Policy & External Affairs Director
International Alliance of Patients' Organizations (IAPO)
Tel: +44 20 7721 7597
Fax: +44 20 7721 7596
Email: policy@patientsorganizations.org
Website: www.patientsorganizations.org .
|
|
|